The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn’t one of them. The 10 stocks that ...

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal ...

Gifting allows recipients to access the article for free. University of Michigan spinout company Courage Therapeutics has raised $7.8 million as part of its seed round, the company announced Friday.

Rapt Therapeutics (RAPT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its ...

I’m referring to the pending announcement of the first clinical data from Summit Therapeutics and its buzzy PD-1-VEGF antibody ivonescimab derived from lung cancer patients in the U.S. and other ...

6 analysts have shared their evaluations of Zevra Therapeutics ZVRA during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their ...

Burt A. Adelman is the founder of Verve Therapeutics, Inc. (founded in 2018) and holds the title of Chairman. He is also the founder of Clear Creek Bio, Inc. Dr. Adelman's current jobs include ...

In this article, we are going to take a look at where Amicus Therapeutics, Inc. (NASDAQ:FOLD) stands against other best low priced biotech stocks to buy now. On May 8, Michael Yee, Senior Biotech ...

In this article, we are going to take a look at where Relay Therapeutics, Inc. (NASDAQ:RLAY) stands against other best low priced biotech stocks to buy now. On May 8, Michael Yee, Senior Biotech ...

CAMBRIDGE, Mass., May 13, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported ...